Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshifumi Maeno

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Clinical Chemistry|October 15, 2005
Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patientsYoshifumi Maeno, Masaaki Inaba, Senji Okuno, et al.
Life Sciences|June 28, 2005
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTHMisako Ueda, Masaaki Inaba, Senji Okuno, et al.
Calcified Tissue International|January 16, 2009
Association of reduction in bone mineral density with mortality in male hemodialysis patientsKaori Kohno, Masaaki Inaba, Senji Okuno, et al.
Calcified Tissue International|September 19, 2009
Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational studyYoshifumi Maeno, Masaaki Inaba, Senji Okuno, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2008
Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patientsSenji Okuno, Eiji Ishimura, Kaori Kohno, et al.
Clinical Calcium|March 19, 2005
[Not Available]Yoshifumi Maeno, Kiyoshi Nakatsuka, Takayuki Yunoki, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2023
Daily Glucose Profiles after Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes MellitusMitsuyoshi Takahara, Toshihiko Shiraiwa, Naoto Katakami, et al.
BMC Endocrine Disorders|June 6, 2022
Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitusMitsuyoshi Takahara, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.
Internal Medicine (Tokyo, Japan)|March 17, 2022
Screening for a Decreased Masticatory Function by a Color-changeable Chewing Gum Test in Patients with Metabolic DiseaseMitsuyoshi Takahara, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.
JMA Journal|November 9, 2023
Association between History of Vaccination and Symptoms at Diagnosis of Coronavirus Disease 2019Toshihiko Shiraiwa, Mitsuyoshi Takahara, Yoshifumi Maeno, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Clinical Chemistry|October 15, 2005
Serum concentrations of cross-linked N-telopeptides of type I collagen: new marker for bone resorption in hemodialysis patientsYoshifumi Maeno, Masaaki Inaba, Senji Okuno, et al.
Life Sciences|June 28, 2005
Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTHMisako Ueda, Masaaki Inaba, Senji Okuno, et al.
Calcified Tissue International|January 16, 2009
Association of reduction in bone mineral density with mortality in male hemodialysis patientsKaori Kohno, Masaaki Inaba, Senji Okuno, et al.
Calcified Tissue International|September 19, 2009
Significant association of fracture of the lumbar spine with mortality in female hemodialysis patients: a prospective observational studyYoshifumi Maeno, Masaaki Inaba, Senji Okuno, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|September 19, 2008
Serum beta2-microglobulin level is a significant predictor of mortality in maintenance haemodialysis patientsSenji Okuno, Eiji Ishimura, Kaori Kohno, et al.
Clinical Calcium|March 19, 2005
[Not Available]Yoshifumi Maeno, Kiyoshi Nakatsuka, Takayuki Yunoki, et al.
Internal Medicine (Tokyo, Japan)|May 24, 2023
Daily Glucose Profiles after Switching from Injectable to Oral Semaglutide in Patients with Type 2 Diabetes MellitusMitsuyoshi Takahara, Toshihiko Shiraiwa, Naoto Katakami, et al.
BMC Endocrine Disorders|June 6, 2022
Improvement of beta-cell function in conjunction with glycemic control after medical nutrition therapy in newly-diagnosed type 2 diabetes mellitusMitsuyoshi Takahara, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.
Internal Medicine (Tokyo, Japan)|March 17, 2022
Screening for a Decreased Masticatory Function by a Color-changeable Chewing Gum Test in Patients with Metabolic DiseaseMitsuyoshi Takahara, Toshihiko Shiraiwa, Yoshifumi Maeno, et al.
JMA Journal|November 9, 2023
Association between History of Vaccination and Symptoms at Diagnosis of Coronavirus Disease 2019Toshihiko Shiraiwa, Mitsuyoshi Takahara, Yoshifumi Maeno, et al.
Pageof 2